Literature DB >> 25217454

Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy.

Stefano Caselli1, Martin S Maron2, Josè A Urbano-Moral2, Natesa G Pandian2, Barry J Maron3, Antonio Pelliccia4.   

Abstract

Identification of hypertrophic cardiomyopathy (HC) in young athletes is challenging when left ventricular (LV) wall thickness is between 13 and 15 mm. The aim of this study was to revise the ability of simple echocardiographic and clinical variables for the differential diagnosis of HC versus athlete's heart. Twenty-eight athletes free of cardiovascular disease were compared with 25 untrained patients with HC, matched for LV wall thickness (13 to 15 mm), age, and gender. Clinical, electrocardiographic, and echocardiographic variables were compared. Athletes had larger LV cavities (60 ± 3 vs 45 ± 5 mm, p <0.001), aortic roots (34 ± 3 vs 30 ± 3 mm, p <0.001), and left atria (42 ± 4 vs 33 ± 5 mm, p <0.001) than patients with HC. LV cavity <54 mm distinguished HC from athlete's heart with the highest sensitivity and specificity (both 100%, p <0.001). Left atrium >40 mm excluded HC with sensitivity of 92% and specificity of 71% (p <0.001). Athletes showed higher e' velocity by tissue Doppler imaging than patients with HC (12.5 ± 1.9 vs 9.3 ± 2.3 cm/second, p <0.001), with values <11.5 cm/second yielding sensitivity of 81% and specificity of 61% for the diagnosis of HC (p <0.001). Absence of diffuse T-wave inversion on electrocardiography (specificity 92%) and negative family history for HC (specificity 100%) also proved useful for excluding HC. In conclusion, in athletes with LV hypertrophy in the "gray zone" with HC, LV cavity size appears the most reliable criterion to help in diagnosis, with a cut-off value of <54 mm useful for differentiation from athlete's heart. Other criteria, including LV diastolic dysfunction, absence of T-wave inversion on electrocardiography, and negative family history, further aid in the differential diagnosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25217454     DOI: 10.1016/j.amjcard.2014.07.070

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  37 in total

1.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

2.  Left and right ventricular longitudinal strain-volume/area relationships in elite athletes.

Authors:  David Oxborough; Annemieke Heemels; John Somauroo; Gavin McClean; Punit Mistry; Rachel Lord; Victor Utomi; Nigel Jones; Dick Thijssen; Sanjay Sharma; Rebecca Osborne; Nicholas Sculthorpe; Keith George
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-21       Impact factor: 2.357

Review 3.  Cardiac Imaging In Athletes.

Authors:  Asaad A Khan; Lucy Safi; Malissa Wood
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Apr-Jun

Review 4.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 5.  Recommendations for exercise and screening for safe athletic participation in hypertensive youth.

Authors:  Carissa M Baker-Smith; Nicholas Pietris; Laide Jinadu
Journal:  Pediatr Nephrol       Date:  2019-04-26       Impact factor: 3.714

Review 6.  Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.

Authors:  George Makavos; Chris Κairis; Maria-Eirini Tselegkidi; Theodoros Karamitsos; Angelos G Rigopoulos; Michel Noutsias; Ignatios Ikonomidis
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

Review 7.  Hypertrophic Cardiomyopathy in Athletes.

Authors:  Aneil Malhotra; Sanjay Sharma
Journal:  Eur Cardiol       Date:  2017-12

Review 8.  Cardiac Imaging in the Athlete: Shrinking the "Gray Zone".

Authors:  Mario R Caruso; Lohit Garg; Matthew W Martinez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-02-03

9.  Position Statement on Indications of Echocardiography in Adults - 2019.

Authors:  Silvio Henrique Barberato; Minna Moreira Dias Romano; Adenalva Lima de Souza Beck; Ana Clara Tude Rodrigues; André Luiz Cerqueira de Almeida; Bruna Morhy Borges Leal Assunção; Eliza de Almeida Gripp; Fabio Villaça Guimarães Filho; Henry Abensur; José Maria Del Castillo; Marcelo Haertel Miglioranza; Marcelo Luiz Campos Vieira; Márcio Vinicius Lins de Barros; Maria do Carmo Pereira Nunes; Maria Estefania Bosco Otto; Renato de Aguiar Hortegal; Rodrigo Bellio de Mattos Barretto; Thais Harada Campos; Vicente Nicoliello de Siqueira; Samira Saady Morhy
Journal:  Arq Bras Cardiol       Date:  2019-08-08       Impact factor: 2.000

10.  Revisiting Athlete's Heart Versus Pathologic Hypertrophy: ARVC and the Right Ventricle.

Authors:  Barry J Maron; Bradley A Maron
Journal:  JACC Cardiovasc Imaging       Date:  2016-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.